Thermo Fisher to Acquire Affymetrix

The boards of both companies have agreed to a $1.3 billion deal, which is subject to Affymetrix shareholder approval.

By | January 11, 2016

WIKIMEDIA, NIAMSThermo Fisher Scientific said Friday (January 8) that it would acquire Affymetrix for $1.3 billion. According to MarketWatch, the boards of both companies have agreed to the deal, which must still be approved by Affymetrix shareholders.

“The acquisition of Affymetrix will strengthen our leadership in biosciences and create new market opportunities for us in genetic analysis,” Thermo Fisher President and CEO Marc Casper said in a statement (via 24/7 Wall Street). Frank Witney, president and CEO of Affymetrix, added: “We will be able to build on our strong history of close collaboration with customers in our target markets by leveraging Thermo Fisher’s deep relationships, particularly in biopharma.”.

(Hat tip: The Wall Street Journal)

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Man Receives First In Vivo Gene-Editing Therapy
  2. Researchers Build a Cancer Immunotherapy Without Immune Cells
  3. Long-term Study Finds That the Pesticide Glyphosate Does Not Cause Cancer
  4. Research Links Gut Health to Neurodegeneration
    The Nutshell Research Links Gut Health to Neurodegeneration

    Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.

RayBiotech